Published in Eur J Appl Physiol on December 01, 2001
Vibration as an exercise modality: how it may work, and what its potential might be. Eur J Appl Physiol (2009) 2.77
Whole-body vibration slows the acquisition of fat in mature female rats. Int J Obes (Lond) (2008) 1.64
Acute whole body vibration training increases vertical jump and flexibility performance in elite female field hockey players. Br J Sports Med (2005) 1.59
Whole body vibration exercise: are vibrations good for you? Br J Sports Med (2005) 1.55
Energy Expenditure and Substrate Oxidation in Response to Side-Alternating Whole Body Vibration across Three Commonly-Used Vibration Frequencies. PLoS One (2016) 1.41
The influence of vibration type, frequency, body position and additional load on the neuromuscular activity during whole body vibration. Eur J Appl Physiol (2012) 1.23
Effects of vibration and resistance training on neuromuscular and hormonal measures. Eur J Appl Physiol (2006) 1.13
The rate of muscle temperature increase during acute whole-body vibration exercise. Eur J Appl Physiol (2008) 1.10
The effects of 11 weeks whole body vibration training on jump height, contractile properties and activation of human knee extensors. Eur J Appl Physiol (2003) 1.02
Vertical whole-body vibration does not increase cardiovascular stress to static semi-squat exercise. Eur J Appl Physiol (2008) 0.97
Acute whole-body vibration elicits post-activation potentiation. Eur J Appl Physiol (2009) 0.96
The potential neural mechanisms of acute indirect vibration. J Sports Sci Med (2011) 0.96
Synchronous whole-body vibration increases VO₂ during and following acute exercise. Eur J Appl Physiol (2011) 0.89
The effect of whole-body vibration frequency and amplitude on the myoelectric activity of vastus medialis and vastus lateralis. J Sports Sci Med (2011) 0.89
Whole-body vibration training effect on physical performance and obesity in mice. Int J Med Sci (2014) 0.88
Energy metabolism in human calf muscle performing isometric plantar flexion superimposed by 20-Hz vibration. Eur J Appl Physiol (2008) 0.87
Ten-week whole-body vibration training improves body composition and muscle strength in obese women. Int J Med Sci (2013) 0.86
Efficacy of WBV as a modality for inducing changes in body composition, aerobic fitness, and muscular strength: a pilot study. Clin Interv Aging (2013) 0.86
Efficacy of a whole-body vibration intervention to effect exercise tolerance and functional performance of the lower limbs of people with chronic obstructive pulmonary disease. BMC Pulm Med (2012) 0.85
Combined whole-body vibration, resistance exercise, and sustained vascular occlusion increases PGC-1α and VEGF mRNA abundances. Eur J Appl Physiol (2012) 0.85
Is leg compression beneficial for alpine skiers? BMC Sports Sci Med Rehabil (2013) 0.84
Whole body vibration improves cognition in healthy young adults. PLoS One (2014) 0.82
Whole body vibration training--improving balance control and muscle endurance. PLoS One (2014) 0.81
Acute and cumulative effects of focused high-frequency vibrations on the endocrine system and muscle strength. Eur J Appl Physiol (2010) 0.81
Fitness efficacy of vibratory exercise compared to walking in postmenopausal women. Eur J Appl Physiol (2009) 0.80
Vibration therapy: clinical applications in bone. Curr Opin Endocrinol Diabetes Obes (2014) 0.80
The effects of vibration therapy on muscle force loss following eccentrically induced muscle damage. Eur J Appl Physiol (2011) 0.80
The addition of synchronous whole-body vibration to battling rope exercise increases skeletal muscle activity. J Musculoskelet Neuronal Interact (2015) 0.78
The effect of whole body vibration exposure on muscle function in children with cystic fibrosis: a pilot efficacy trial. J Clin Med Res (2013) 0.78
EMG and heart rate responses decline within 5 days of daily whole-body vibration training with squatting. PLoS One (2014) 0.78
In the unloaded lower leg, vibration extrudes venous blood out of the calf muscles probably by direct acceleration and without arterial vasodilation. Eur J Appl Physiol (2014) 0.77
Acute and Chronic Whole-Body Vibration Exercise does not Induce Health-Promoting Effects on The Blood Profile. J Hum Kinet (2015) 0.77
The effects of acute whole body vibration as a recovery modality following high-intensity interval training in well-trained, middle-aged runners. Eur J Appl Physiol (2008) 0.76
Determining the Posture and Vibration Frequency that Maximize Pelvic Floor Muscle Activity During Whole-Body Vibration. Med Sci Monit (2016) 0.75
Does short-term whole-body vibration training affect arterial stiffness in chronic stroke? A preliminary study. J Phys Ther Sci (2016) 0.75
Cardiopulmonary response during whole-body vibration training in patients with severe COPD. ERJ Open Res (2017) 0.75
Acute effects of unilateral whole body vibration training on single leg vertical jump height and symmetry in healthy men. J Phys Ther Sci (2015) 0.75
A novel compression garment with adhesive silicone stripes improves repeated sprint performance - a multi-experimental approach on the underlying mechanisms. BMC Sports Sci Med Rehabil (2014) 0.75
Short Duration Small Sided Football and to a Lesser Extent Whole Body Vibration Exercise Induce Acute Changes in Markers of Bone Turnover. Biomed Res Int (2016) 0.75
Clinical applications of vibration therapy in orthopaedic practice. Muscles Ligaments Tendons J (2016) 0.75
A comparison of whole-body vibration and resistance training on total work in the rotator cuff. J Athl Train (2009) 0.75
Vibration training and body fat: a comment on Artero et al. (2011). Eur J Appl Physiol (2011) 0.75
The Short-Term Effect of Whole Body Vibration Training on Sprint Start Performance in Collegiate Athletes. Int J Exerc Sci (2009) 0.75
Effects of whole-body vibration training on fibrinolytic and coagulative factors in healthy young men. J Res Med Sci (2014) 0.75
Loading and concurrent synchronous whole-body vibration interaction increases oxygen consumption during resistance exercise. J Sports Sci Med (2013) 0.75
Metabolic responses to whole-body vibration: effect of frequency and amplitude. Eur J Appl Physiol (2016) 0.75
EFFECT OF MECHANICAL VIBRATION GENERATED IN OSCILLATING/VIBRATORY PLATFORM ON THE CONCENTRATION OF PLASMA BIOMARKERS AND ON THE WEIGHT IN RATS. Afr J Tradit Complement Altern Med (2017) 0.75
Vibration-related extrusion of capillary blood from the calf musculature depends upon directions of vibration of the leg and of the gravity vector. Eur J Appl Physiol (2017) 0.75
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals. Bone (2004) 1.94
Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut (1993) 1.83
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study. Osteoporos Int (2006) 1.75
Acute physiological effects of exhaustive whole-body vibration exercise in man. Clin Physiol (2000) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Bone-muscle strength indices for the human lower leg. Bone (2000) 1.65
Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int (1999) 1.59
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions. J Musculoskelet Neuronal Interact (2010) 1.53
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast (2009) 1.47
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Oxygen uptake in whole-body vibration exercise: influence of vibration frequency, amplitude, and external load. Int J Sports Med (2002) 1.41
Osteoporosis changes the amount of vertebral trabecular bone at risk of fracture but not the vertebral load distribution. Spine (Phila Pa 1976) (2001) 1.24
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
Assessment of anthropometric, systemic, and lifestyle factors influencing bone status in the legs of spinal cord injured individuals. Osteoporos Int (2004) 1.18
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone (2007) 1.15
Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol (1989) 1.14
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int (2011) 1.13
Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int (2000) 1.13
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int (2004) 1.10
European semi-anthropomorphic spine phantom for the calibration of bone densitometers: assessment of precision, stability and accuracy. The European Quantitation of Osteoporosis Study Group. Osteoporos Int (1995) 1.08
Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int (1997) 1.06
Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res (1997) 1.05
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut (2002) 1.04
Bone loss and steady state after spinal cord injury: a cross-sectional study using pQCT. J Musculoskelet Neuronal Interact (2004) 1.03
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int (2011) 1.03
Recovery of muscle atrophy and bone loss from 90 days bed rest: results from a one-year follow-up. Bone (2008) 1.01
Adjusting for the partial volume effect in cortical bone analyses of pQCT images. J Musculoskelet Neuronal Interact (2004) 0.99
Resistive vibration exercise reduces lower limb muscle atrophy during 56-day bed-rest. J Musculoskelet Neuronal Interact (2009) 0.97
Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism. Osteoporos Int (2009) 0.96
Influence of muscle strength on bone strength during childhood and adolescence. Horm Res (1996) 0.95
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther (2002) 0.95
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
TBS result is not affected by lumbar spine osteoarthritis. Osteoporos Int (2014) 0.94
Evidence for an additional effect of whole-body vibration above resistive exercise alone in preventing bone loss during prolonged bed rest. Osteoporos Int (2010) 0.94
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporos Int (2011) 0.94
Measurements of vertebral shape by radiographic morphometry: sex differences and relationships with vertebral level and lumbar lordosis. Skeletal Radiol (1998) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
Decline of specific peak jumping power with age in master runners. J Musculoskelet Neuronal Interact (2008) 0.92
Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol (1992) 0.92
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporos Int (2007) 0.92
Fractal analysis of proximal femur radiographs: correlation with biomechanical properties and bone mineral density. Osteoporos Int (1999) 0.91
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporos Int (2012) 0.90
Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. J Musculoskelet Neuronal Interact (2007) 0.90
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int (2009) 0.90
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis. Osteoporos Int (2007) 0.90
[MRI of the knee joint of young soccer players. Are there early changes of the internal structures of the knee due to competitive sports?]. Rofo (1994) 0.89
Efficacy and safety of ibandronate given by intravenous injection once every 3 months. Bone (2004) 0.89
Low grip strength is associated with bone mineral density and vertebral fracture in women. Rheumatology (Oxford) (2005) 0.89
European semi-anthropomorphic phantom for the cross-calibration of peripheral bone densitometers: assessment of precision accuracy and stability. Bone Miner (1994) 0.89
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies. Osteoporos Int (2013) 0.88
Falls explain between-center differences in the incidence of limb fracture across Europe. Bone (2002) 0.88
Dual X-ray absorptiometry--cross-calibration and normative reference ranges for the spine: results of a European Community Concerted Action. Bone (1995) 0.88
Dual X-ray absorptiometry of the proximal femur: normal European values standardized with the European Spine Phantom. J Bone Miner Res (1995) 0.87
Vertebral fractures in men and women: how discriminative are bone mass measurements? Br J Radiol (1995) 0.86
The 2nd Berlin BedRest Study: protocol and implementation. J Musculoskelet Neuronal Interact (2010) 0.86
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int (2002) 0.86
Whole body vibration in cystic fibrosis--a pilot study. J Musculoskelet Neuronal Interact (2008) 0.86
Strength, size and activation of knee extensors followed during 8 weeks of horizontal bed rest and the influence of a countermeasure. Eur J Appl Physiol (2006) 0.85
Severe developmental bone phenotype in ClC-7 deficient mice. Dev Biol (2010) 0.85
Prediction of osteoporotic fractures by bone densitometry and COLIA1 genotyping: a prospective, population-based study in men and women. Osteoporos Int (2001) 0.85
Variation in vertebral height ratios in population studies. European Vertebral Osteoporosis Study Group. J Bone Miner Res (1994) 0.85
Orientation-dependent changes in MR signal intensity of articular cartilage: a manifestation of the "magic angle" effect. Skeletal Radiol (1998) 0.85
Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol (1997) 0.84
Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women. Osteoporos Int (2000) 0.84
Physical performance in aging elite athletes--challenging the limits of physiology. J Musculoskelet Neuronal Interact (2004) 0.84
Measurement imprecision in vertebral morphometry of spinal radiographs obtained in the European Prospective Osteoporosis Study: consequences for the identification of prevalent and incident deformities. Br J Radiol (1999) 0.83
International variation in proximal femur bone mineral density. Osteoporos Int (2010) 0.83
Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin Endocrinol (Oxf) (1992) 0.83
Comments on the hypotheses underlying fracture risk assessment in osteoporosis as proposed by the World Health Organization. Calcif Tissue Int (1999) 0.82
Cross-sectional assessment of neuromuscular function using mechanography in women and men aged 20-85 years. J Musculoskelet Neuronal Interact (2013) 0.82
Relationship between risk factors and QUS in a European Population: The OPUS study. Bone (2006) 0.82
A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception (2004) 0.82
Changes in lower extremity muscle function after 56 days of bed rest. J Appl Physiol (1985) (2011) 0.82
Multicentre European COMAC-BME study on the standardisation of bone densitometry procedures. Technol Health Care (1993) 0.82
Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise. J Musculoskelet Neuronal Interact (2013) 0.81
Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group. Osteoporos Int (1997) 0.81
[Computerized tomography determination of bone mineral content in quantitative diagnosis of osteoporosis]. Orthopade (1989) 0.81
Highly demanding resistive vibration exercise program is tolerated during 56 days of strict bed-rest. Int J Sports Med (2006) 0.81
Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study. Calcif Tissue Int (1999) 0.81
Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. J Bone Miner Res (1997) 0.81
Age-dependency in bone mass and geometry: a pQCT study on male and female master sprinters, middle and long distance runners, race-walkers and sedentary people. J Musculoskelet Neuronal Interact (2009) 0.80
Bone structure and density via HR-pQCT in 60d bed-rest, 2-years recovery with and without countermeasures. J Musculoskelet Neuronal Interact (2011) 0.80
ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion. Bone (2013) 0.80
Oral weekly ibandronate prevents bone loss in postmenopausal women. J Intern Med (2003) 0.80